Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis

被引:0
作者
Karin Oechsle
Victoria Lange-Brock
Andreas Kruell
Carsten Bokemeyer
Maike de Wit
机构
[1] University Cancer Center Hamburg-Eppendorf,Department of Oncology/Hematology/Bone Marrow Transplantation/Pneumology
[2] Vivantes Klinikum Neukoeln,Clinic of Internal Medicine–Hematology and Oncology
[3] University Cancer Center Hamburg-Eppendorf,Department of Radio
来源
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷
关键词
Leptomeningeal metastases; Meningeosis carcinomatosa; Intrathecal chemotherapy; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1729 / 1735
页数:6
相关论文
共 50 条
  • [41] Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: Retrospective analysis of 113 patients
    Beldi, Debora
    Jereczek-Fossa, Barbara A.
    D'Onofrio, Alberto
    Gambaro, Giuseppina
    Fiore, Maria Rosaria
    Pia, Francesco
    Chiesa, Fausto
    Orecchia, Roberto
    Krengli, Marco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04): : 1051 - 1058
  • [42] Prognostic factors in breast phyllodes tumors: a nomogram based on a retrospective cohort study of 404 patients
    Zhou, Zhi-Rui
    Wang, Chen-Chen
    Sun, Xiang-Jie
    Yang, Zhao-Zhi
    Chen, Xing-Xing
    Shao, Zhi-Ming
    Yu, Xiao-Li
    Guo, Xiao-Mao
    CANCER MEDICINE, 2018, 7 (04): : 1030 - 1042
  • [43] The role of prognostic factors on survival of patients with brain metastases
    Grgic, LM
    Nishliu, M
    Santek, F
    Rakusic, Z
    Kukura, V
    Podolski, P
    Stepanic, V
    Santek, MT
    Budisic, Z
    Erak, V
    NEUROLOGIA CROATICA, 2004, 53 (3-4): : 61 - 68
  • [44] Prognostic factors in hepatocellular carcinoma patients with bone metastases
    Kim, Sungmin
    Choi, Youngmin
    Kwak, Dong-Won
    Lee, Hyung Sik
    Hur, Won-Joo
    Baek, Yang Hyun
    Lee, Sung Wook
    RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 207 - 214
  • [45] Prognostic Factors for Survival in Melanoma Patients With Brain Metastases
    Davies, Michael A.
    Liu, Ping
    McIntyre, Susan
    Kim, Kevin B.
    Papadopoulos, Nicholas
    Hwu, Wen-Jen
    Hwu, Patrick
    Bedikian, Agop
    CANCER, 2011, 117 (08) : 1687 - 1696
  • [46] Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1 043 patients
    Bollen, Laurens
    van der Linden, Yvette M.
    Pondaag, Willem
    Fiocco, Marta
    Pattynama, Bas P. M.
    Marijnen, Corrie A. M.
    Nelissen, Rob G. H. H.
    Peul, Wilco C.
    Dijkstra, P. D. Sander
    NEURO-ONCOLOGY, 2014, 16 (07) : 991 - 998
  • [47] Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies
    Saginc, Halil
    Baltalarli, P. Bahar
    Sagtas, Ergin
    Coskun, M. Erdal
    TURKISH NEUROSURGERY, 2020, 30 (06) : 822 - 831
  • [48] Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors
    Vesper, J.
    Graf, E.
    Wille, C.
    Tilgner, J.
    Trippel, M.
    Nikkhah, G.
    Ostertag, C. B.
    BMC NEUROLOGY, 2009, 9 : 33
  • [49] Number of Metastases, Serum Lactate Dehydrogenase Level, and Type of Treatment Are Prognostic Factors in Patients With Brain Metastases of Malignant Melanoma
    Eigentler, Thomas K.
    Figl, Adina
    Krex, Dietmar
    Mohr, Peter
    Mauch, Cornelia
    Rass, Knut
    Bostroem, Azize
    Heese, Oliver
    Koelbl, Oliver
    Garbe, Claus
    Schadendorf, Dirk
    CANCER, 2011, 117 (08) : 1697 - 1703
  • [50] Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients
    Pontoriero, Antonio
    Conti, Alfredo
    Iati, Giuseppe
    Mondello, Stefania
    Aiello, Dario
    Rifatto, Carmen
    Risoleti, Edoarda
    Mazzei, Micol
    Tomasello, Francesco
    Pergolizzi, Stefano
    De Renzis, Costantino
    NEUROSURGICAL REVIEW, 2016, 39 (03) : 495 - 503